Opioids in chronic noncancer pain

References

• Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician12(4), E35–E70 (2009).
   PubMed Web of Science ®Google Scholar
• Tripp DA, VanDenKerkhof EG, McAlister M. Prevalence and determinants of pain and pain-related disability in urban and rural settings in southeastern Ontario. Pain Res. Manag.11(4), 225–233 (2006).
   PubMedGoogle Scholar
• Blyth FM. Chronic pain – is it a public health problem? Pain137(3), 465–466 (2008).
   PubMed Web of Science ®Google Scholar
• Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain10(4), 287–333 (2006).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Boswell MV, Singh V et al. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician12(4), 699–802 (2009).
   PubMed Web of Science ®Google Scholar
• Gureje O. Comorbidity of pain and anxiety disorders. Curr. Psychiatry Rep.10(4), 318–322 (2008).
   PubMedGoogle Scholar
• Eriksen J, Ekholm O, Sjøgren P, Rasmussen NK. Development of and recovery from long-term pain. A 6-year follow-up study of a cross-section of the adult Danish population. Pain108(1–2), 154–162 (2004).
   PubMed Web of Science ®Google Scholar
• Pleis JR, Lethbridge-Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. National Center for Health Statistics. Vital Health Stat.10(235), 1–153 (2007).
   Google Scholar
• Harkness EF, Macfarlane GJ, Silman AJ, McBeth J. Is musculoskeletal pain more common now than 40 years ago?: two population-based cross-sectional studies. Rheumatology (Oxford)44(7), 890–895 (2005).
   PubMed Web of Science ®Google Scholar
• Freburger JK, Holmes GM, Agans RP et al. The rising prevalence of chronic low back pain. Arch. Intern. Med.169(3), 251–258 (2009).
   PubMed Web of Science ®Google Scholar
• Martin BI, Deyo RA, Mirza SK et al. Expenditures and health status among adults with back and neck problems. JAMA299(6), 656–664 (2008).
   PubMed Web of Science ®Google Scholar
• Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet354(9186), 1248–1252 (1999).
   PubMed Web of Science ®Google Scholar
• Trescot AM, Helm S, Hansen H et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) guidelines. Pain Physician11(2 Suppl.), S5–S62 (2008).
   PubMed Web of Science ®Google Scholar
• Yeung SS, Genaidy A, Deddens J, Alhemood A, Leung PC. Prevalence of musculoskeletal symptoms in single and multiple body regions and effects of perceived risk of injury among manual handling workers. Spine (Phila Pa 1976)27(19), 2166–2172 (2002).
   PubMed Web of Science ®Google Scholar
• Moulin DE, Clark AJ, Speechley M, Morley-Forster PK. Chronic pain in Canada – prevalence, treatment, impact and the role of opioid analgesia. Pain Res. Manage.7(4), 179–184 (2002).
   PubMedGoogle Scholar
• Mailis-Gagnon A, Nicholson K, Yegneswaran B, Zurowski M. Pain characteristics of adults 65 years of age and older referred to a tertiary care pain clinic. Pain Res. Manage.13(5), 389–394 (2008).
   PubMed Web of Science ®Google Scholar
• MacFarlane GJ, McBeth J, Garrow A, Silman AJ. Life is as much a pain as it ever was. Br. Med. J.321(7265), 897 (2000).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician11(2 Suppl.), S63–S88 (2008).
   PubMed Web of Science ®Google Scholar
• Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician11(2 Suppl.), S181–S200 (2008).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician10(3), 479–491 (2007).
   PubMedGoogle Scholar
• Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J. Pain10(2), 147–159 (2009).
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J. Pain10(2), 131–146 (2009).
   PubMed Web of Science ®Google Scholar
• Woodcock J. A difficult balance – pain management, drug safety, and the FDA. N. Engl. J. Med.361(22), 2105–2107 (2009).
   PubMed Web of Science ®Google Scholar
• Warner, M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief.22, 1–8 (2009).
   PubMedGoogle Scholar
• Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am. J. Addict.18(1), 5–14 (2009).
   PubMed Web of Science ®Google Scholar
• Overdose deaths involving prescription opioids among Medicaid enrollees – Washington, 2004–2007. MMWR Weekly58(42), 1171–1175 (2009).
   PubMedGoogle Scholar
• Hall AJ, Logan JE, Toblin RL et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA300(22), 2613–2620 (2008).
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA297(3), 249–251 (2007).
   PubMed Web of Science ®Google Scholar
• Large RG, Schug SA. Opioids for chronic pain of non-malignant origin – caring or crippling. Health Care Anal.3(1), 5–11(1995).
   PubMed Web of Science ®Google Scholar
• Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain125(1–2), 172–179 (2006).
   PubMed Web of Science ®Google Scholar
• Martell BA, O’Connor PG, Kerns RD et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann. Intern. Med.146(2), 116–127 (2007).
   PubMed Web of Science ®Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ174(11), 1589–1594 (2006).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain (review). Cochrane Database Syst. Rev.3, CD006146 (2006).
   Google Scholar
• Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low back pain (review). Cochrane Database Syst. Rev.3, CD004959 (2007).
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: a systematic review and metaanalysis. J. Rheumatol.34(3), 543–555 (2007).
   PubMed Web of Science ®Google Scholar
• Sandoval JA, Furlan AD, Mailis-Gagnon AM. Oral methadone for chronic noncancer pain: a systemic literature review of reasons for administration, prescription patterns, effectiveness, and side effects. Clin. J. Pain21(6), 503–512 (2005).
   PubMed Web of Science ®Google Scholar
• Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J. Pain Symptom Manage.35(2), 214–228 (2008).
   PubMed Web of Science ®Google Scholar
• Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain112(3), 372–380 (2004).
   PubMed Web of Science ®Google Scholar
• Rauck RL. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review. Pain Pract.9(6), 468–479 (2009).
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain10(2), 113–130 (2009).
   PubMed Web of Science ®Google Scholar
• Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J. Pain Symptom Manage.26(5), 1026–1048 (2003).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain. Clin. J. Pain24(6), 469–478 (2008).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Mao J. Opioid therapy for chronic pain. N. Engl. J. Med.349(20), 1943–1953 (2003).
   PubMed Web of Science ®Google Scholar
• Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine (Phila Pa 1976)30(22), 2484–2490 (2005).
   PubMed Web of Science ®Google Scholar
• Caldwell JR, Rapoport RJ, Davis JC et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo controlled, double-blind trial and an open-label extension trial. J. Pain Symptom Manage.23(4), 278–291 (2002).
   PubMed Web of Science ®Google Scholar
• Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J. Pain Symptom Manage.7(2), 69–77 (1992).
   PubMed Web of Science ®Google Scholar
• Harati Y, Gooch C, Swenson M et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J. Diabetes Complications14(2), 65–70 (2000).
   PubMed Web of Science ®Google Scholar
• Fredheim OM, Kaasa S, Dale O, Klepstad P, Landrø NI, Borchgrevink PC. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study. Palliat. Med.20(1), 35–41 (2006).
   PubMed Web of Science ®Google Scholar
• McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study. Am. J. Ther.12(2), 106–112 (2005).
   PubMedGoogle Scholar
• Roth SH, Fleischmann RM, Burch FX et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch. Intern. Med.160(6), 853–860 (2000).
   PubMed Web of Science ®Google Scholar
• Milligan K, Lanteri-Minet M, Borchert K et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J. Pain2(4), 197–204 (2001).
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Parpa E, Tsilika E et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J. Pain4(6), 298–306 (2003).
   PubMed Web of Science ®Google Scholar
• Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N. Protocol TRP-CAN-1 Study Group. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J. Rheumatol.31(12), 2454–2463 (2004).
   PubMed Web of Science ®Google Scholar
• Allan L, Hays H, Jensen NH et al. Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br. Med. J.322(7295), 1154–1158 (2001).
   PubMed Web of Science ®Google Scholar
• Adams EH, Breiner S, Cicero TJ et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J. Pain Symptom Manage.31(5), 465–476 (2006).
   PubMed Web of Science ®Google Scholar
• Dillie KS, Fleming MF, Mundt MP, French MT. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. Am. Board Fam. Med.21(2), 108–117 (2008).
   PubMed Web of Science ®Google Scholar
• Jensen MK, Thomsen AB, Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur. J. Pain10(5), 423–433 (2006).
   PubMed Web of Science ®Google Scholar
• Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesth. Analg.102(5), 1473–1479 (2006).
   PubMed Web of Science ®Google Scholar
• Rauck RL, Bookbinder SA, Bunker TR, Alftine CD. A randomized, open-label, multicenter trial comparing once-a-day Avinza (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (Oxycodone hydrochloride controlled release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial. J. Opioid Manage.3(1), 35–43 (2007).
   PubMedGoogle Scholar
• Adams EH, Chwiecko P, Ace-Wagoner Y et al. A study of Avinza (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions – the ACCPT study. Pain Pract.6(4), 254–264 (2006).
   PubMedGoogle Scholar
• Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine (Phila Pa 1976).30(9), 1075–1081 (2005).
   PubMed Web of Science ®Google Scholar
• Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery, and late opioid use. Spine (Phila Pa 1976)32(19), 2127–2132 (2007).
   PubMed Web of Science ®Google Scholar
• Lawrence JT, London N, Bohlman HH, Chin KR. Preoperative narcotic use as a predictor of clinical outcome. Spine (Phila Pa 1976)33(19), 2074–2078 (2008).
   PubMed Web of Science ®Google Scholar
• Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Phila Pa 1976).28(2), 143–150 (2003).
   PubMed Web of Science ®Google Scholar
• Strassels SA. Cognitive effects of opioids. Curr. Pain Headache Rep.12(1), 32–36 (2008).
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J. Pain Symptom Manage.25(6), 559–577 (2003).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician12(1), 259–267 (2009).
   PubMed Web of Science ®Google Scholar
• Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B. Increasing deaths from opioid analgesics in the United States: an evaluation in an interventional pain management practice. J. Opioid Manage.4(5), 271–283 (2008).
   PubMedGoogle Scholar
• Benyamin R, Trescot A, Datta S et al. Opioid complications and side effects. Pain Physician11(2 Suppl.), S105–S120 (2008).
   PubMed Web of Science ®Google Scholar
• Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur. J. Pain11(5), 490–518 (2007).
   PubMed Web of Science ®Google Scholar
• Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician10(2), 357–366 (2007).
   PubMedGoogle Scholar
• Mercadante S. Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain74(1), 5–9 (1998).
   PubMed Web of Science ®Google Scholar
• Han PK, Arnold R, Bond G, Janson D, Abu-Elmagd K. Myoclonus secondary to withdrawal from transdermal fentanyl: case report and literature review. J. Pain Symptom Manage.23(1), 66–72 (2002).
   PubMed Web of Science ®Google Scholar
• Moore P, Dimsdale JE. Opioids, sleep, and cancer-related fatigue. Med. Hypotheses.58(1), 77–82 (2002).
   PubMed Web of Science ®Google Scholar
• Ersek M, Cherrier MM, Overman SS, Irving GA. The cognitive effects of opioids. Pain Manag. Nurs.5(2), 75–93 (2004).
   PubMedGoogle Scholar
• Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician11(2 Suppl.), S133–S154 (2008).
   PubMed Web of Science ®Google Scholar
• Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician10(3), 467–472 (2007).
   PubMedGoogle Scholar
• Collett BJ. Opioid tolerance: the clinical perspective. Br. J. Anaesth.81(1), 58–68 (1998).
   PubMed Web of Science ®Google Scholar
• Cepeda-Benito A, Davis KW, Harraid JH. Associative and behavioral tolerance to the analgesic effects of nicotine in rats: tail flick and paw-lick assays. Psychopharmacology (Berl.)180(2), 224–233 (2005).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC. Opioids for chronic pain: taking stock. Pain125(1–2), 3–4 (2006).
   PubMed Web of Science ®Google Scholar
• Trang T, Quirion R, Jhamandas K. The spinal basis of opioid tolerance and physical dependence: involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides26(8), 1346–1355 (2005).
   PubMed Web of Science ®Google Scholar
• Athanasos P, Smith CS, White JM, Somogyi AA, Bochner F, Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain120(3), 267–275 (2006).
   PubMed Web of Science ®Google Scholar
• Stephanou A, Fitzharris P, Knight RA, Lightman SL. Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes. Brain Behav. Immun.5(4), 319–327 (1991).
   PubMed Web of Science ®Google Scholar
• Peterson PK, Molitor TW, Chao CC. The opioid-cytokine connection. J. Neuroimmunol.83(1–2), 63–69 (1998).
   PubMed Web of Science ®Google Scholar
• Chuang TK, Killam KF Jr, Chuang LF et al. Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun.216(3), 922–930 (1995).
   PubMed Web of Science ®Google Scholar
• Radulovic J, Jankovic BD. Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat. Brain Res.661(1–2), 89–195 (1994).
   Web of Science ®Google Scholar
• Dimitrijevic M, Stanojevic S, Kovacevic-Jovanovic V, Miletic T, Vujic-Redzic V, Radulovic J. Modulation of humoral immune responses in the rat by centrally applied met-enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors. Immunopharmacology49(3), 255–262 (2000).
   PubMed Web of Science ®Google Scholar
• Pacifici R, Patrini G, Venier I, Parolaro D, Zuccaro P, Gori E. Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates. J. Pharmacol. Exp. Ther.269(3), 1112–1116 (1994).
   PubMed Web of Science ®Google Scholar
• Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J. Pain3(5), 377–384 (2002).
   PubMed Web of Science ®Google Scholar
• Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J. Pain9(1), 28–36 (2008).
   PubMed Web of Science ®Google Scholar
• Daniell HW. DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J. Pain7(12), 901–907 (2006).
   PubMed Web of Science ®Google Scholar
• Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J. Pain7(3), 200–210 (2006).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Comitini G, Petraglia F, Volpe A, Genazzani AR. Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol.23(1–2), 67–73 (1986).
   PubMed Web of Science ®Google Scholar
• Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J. Pain Symptom Manage.26(5), 1055–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J. Clin. Endocrinol. Metab.90(1), 203–206 (2005).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician8(4), 335–347 (2005).
   PubMedGoogle Scholar
• Oltmanns KM, Fehm HL, Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J. Intern. Med.257(5), 478–480 (2005).
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Volpe A, Farci G et al. Hypothalamus–pituitary–adrenal axis of heroin addicts. Drug Alcohol Depend.15(4), 361–366 (1985).
   PubMed Web of Science ®Google Scholar
• Hemmings R, Fox G, Tolis G. Effect of morphine on the hypothalamic–pituitary axis in postmenopausal women. Fertil. Steril.37(3), 389–391 (1982).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Porro C, Facchinetti F et al. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci.38(23), 2103–2110 (1986).
   PubMed Web of Science ®Google Scholar
• Raff H, Norton AJ, Flemma RJ, Findling JW. Inhibition of the adrenocorticotropin response to surgery in humans: interaction between dexamethasone and fentanyl. J. Clin. Endocrinol. Metab.65(2), 295–298 (1987).
   PubMed Web of Science ®Google Scholar
• Abs R, Verhelst J, Maeyaert J et al. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab.85(6), 2215–2222 (2000).
   PubMed Web of Science ®Google Scholar
• Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J. Pain Symptom Manage.9(2), 126–131 (1994).
   PubMed Web of Science ®Google Scholar
• Hall GM, Lacoumenta S, Hart GR, Burrin JM. Site of action of fentanyl in inhibiting the pituitary–adrenal response to surgery in man. Br. J. Anaesth.65(2), 251–253 (1990).
   PubMed Web of Science ®Google Scholar
• Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am. J. Hosp. Palliat. Care22(4), 291–294 (2005).
   PubMedGoogle Scholar
• Silverman S. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician12(3), 679–684 (2009).
   PubMed Web of Science ®Google Scholar
• Mao J, Sung B, Ji RR, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J. Neurosci.22(17), 7650–7661 (2002).
   PubMed Web of Science ®Google Scholar
• Mercadante S, Ferrera P, Villari P, Arcuri E. Hyperalgesia: an emerging iatrogenic syndrome. J. Pain Symptom Manage.26(2), 769–775 (2003).
   PubMed Web of Science ®Google Scholar
• Pud D, Cohen D, Lawental E, Eisenberg E. Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend.82(3), 218–223 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen SP, Christo PJ, Wang S et al. The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus. Reg. Anesth. Pain Med.33(3), 199–206 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Atluri S, Trescot A, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician11(2 Suppl.), S155–S180 (2008).
   PubMed Web of Science ®Google Scholar
• Ives TJ, Chelminski PR, Hammett-Stabler CA et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv. Res.6, 46 (2006).
   PubMed Web of Science ®Google Scholar
• Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain129(3), 355–362 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy R. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA289(18), 2370–2378 (2003).
   PubMed Web of Science ®Google Scholar
• Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J. Pain8(7), 573–582 (2007).
   PubMed Web of Science ®Google Scholar
• Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician10(3), 399–424 (2007).
   PubMedGoogle Scholar
• Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study. Pain Physician7(4), 431–437 (2004).
   PubMedGoogle Scholar
• Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC, Fellows B. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J. KY Med. Assoc.101(11), 511–517 (2003).
   PubMedGoogle Scholar
• Manchikanti L, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. J. KY Med. Assoc.103(2), 55–62 (2005).
   PubMedGoogle Scholar
• Manchikanti L, Damron KS, Beyer CD, Pampati V. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management. Pain Physician6(3), 281–285 (2003).
   PubMedGoogle Scholar
• Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician6(2), 173–178 (2003).
   PubMedGoogle Scholar
• Manchikanti L, Manchukonda R, Pampati V et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician9(2), 123–129 (2006).
   PubMedGoogle Scholar
• Manchikanti L, Damron KS, Pampati V, McManus CD, Weaver SE. Prospective evaluation of patients with increasing opiate needs: prescription opiate abuse and illicit drug use. Pain Physician7(3), 339–344 (2004).
   PubMedGoogle Scholar
• Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician9(3), 215–225 (2006).
   PubMedGoogle Scholar
• Manchikanti L, Manchukonda R, Pampati V, Damron KS. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician8(3), 257–261 (2005).
   PubMedGoogle Scholar
• Manchikanti L, Pampati V, Damron KS, McManus CD. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use? Pain Physician7(1), 71–75 (2004).
   PubMedGoogle Scholar
• Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician9(1), 57–60 (2006).
   PubMedGoogle Scholar
• Evans M, Kriger S, Gunn J, Schwilke G. Effective monitoring of opiates in chronic pain patients. Pract. Pain Manag.9(6), 32–33 (2009).
   Google Scholar
• Couto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul. Health Manage.12(4), 185–190 (2009).
   PubMed Web of Science ®Google Scholar
• Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med.8(7), 573–584 (2007).
   PubMed Web of Science ®Google Scholar
• White AG, Birnbaum HG, Mareva MN et al. Direct costs of opioid abuse in an insured population in the United States. J. Manag. Care Pharm.11(6), 469–479 (2005).
   PubMedGoogle Scholar
• Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med.8(2), 171–183 (2007).
   PubMed Web of Science ®Google Scholar
• Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med.10(3), 537–548 (2009).
   PubMed Web of Science ®Google Scholar
• Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst. Use Misuse41(2), 1–10 (2006).
   PubMed Web of Science ®Google Scholar
• Inciardi JA, Surratt HL. Research Issues and Experiences in Studying Prescription Drug Diversion. Presented at: College on Problems of Drug Dependence: Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions Conference. North Bethesda, MD, USA, 19–20 April 2005.
   Google Scholar
• Smith HS, Kirsh KL, Passick SD. Chronic opioid therapy issues associated with opioid abuse potential. J. Opioid Manage.5(5), 287–300 (2009).
   PubMedGoogle Scholar
• Smith HS, Kirsch KL. Identifying and managing the risk of opioid misuse. Therapy6(5), 685–693 (2009).
   Google Scholar
• Cone J, Heit H, Caplan YH, Gourlay D. Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. J. Anal. Toxicol.30(1), 1–5 (2006).
   PubMed Web of Science ®Google Scholar
• Wasan AD, Michna E, Janfaza D, Greenfield S, Teter CJ, Jamison R. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine. Pain Med.9(7), 918–923 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Malla Y, Wargo BW et al. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Pain Physician13(1), E1–E22 (2010).
   Google Scholar
• Oyler JM, Cone EJ, Joseph RE Jr, Huestis MA. Identification of hydrocodone in human urine following codeine administration. J. Anal. Toxicol.24(7), 530–535 (2000).
   PubMed Web of Science ®Google Scholar
• Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgrad. Med.121(4), 91–102 (2009).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: a preliminary report of a randomized, double-blind controlled trial; Clinical Trial NCT00355706. Pain Physician11, 491–504 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Falco FJ, Cash KA, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: a randomized double-blind, controlled trial with one-year follow-up. Spine (Phila Pa 1976)33, 1813–1820 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: one-year follow-up of a randomized, double-blind controlled trial: Clinical Trial NCT00355914. Pain Physician11, 121–132 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: part 1. Discogenic pain without disc herniation or radiculitis. Pain Physician11, 785–800 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: part 2. Disc herniation and radiculitis. Pain Physician11, 801–815 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: part 3. Post surgery syndrome. Pain Physician11, 817–831 (2008).
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Cash KA, McManus CD, Pampati V, Abdi S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: part 4. Spinal stenosis. Pain Physician11, 833–848 (2008).
   PubMed Web of Science ®Google Scholar
• Smith HS, Deer TR, Staats PS, Singh V, Sehgal N, Cordner H. Intrathecal drug delivery. Pain Physician11(2), S89–S104 (2008).
   PubMed Web of Science ®Google Scholar
• Smith H. Peripherally-acting opioids. Pain Physician11(2), S121–S132 (2008).
   PubMedGoogle Scholar